Literature DB >> 5488205

Drug dosage in patients with impaired renal function.

L Dettli, P Spring, R Habersang.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5488205

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  24 in total

1.  Elimination kinetics of sulfadiazine in patients with normal and impaired renal function.

Authors:  E E Ohnhaus; P Spring
Journal:  J Pharmacokinet Biopharm       Date:  1975-06

2.  Pharmacokinetics in the elderly.

Authors:  E J Triggs; R L Nation; A Long; J J Ashley
Journal:  Eur J Clin Pharmacol       Date:  1975       Impact factor: 2.953

Review 3.  Individualising gentamicin dosage regimens. A comparative review of selected models, data fitting methods and monitoring strategies.

Authors:  R W Jelliffe; T Iglesias; A K Hurst; K A Foo; J Rodriguez
Journal:  Clin Pharmacokinet       Date:  1991-12       Impact factor: 6.447

Review 4.  Cephalexin: a review of its antibacterial, pharmacological and therapeutic properties.

Authors:  T M Speight; R N Brogden; G S Avery
Journal:  Drugs       Date:  1972       Impact factor: 9.546

5.  Proceedings: Digoxin dosage in patients with impaired kidney function.

Authors:  L Dettli; E E Ohnhaus; P Spring
Journal:  Br J Pharmacol       Date:  1972-02       Impact factor: 8.739

6.  Translation of pharmacokinetics to clinical medicine.

Authors:  L Dettli
Journal:  J Pharmacokinet Biopharm       Date:  1973-10

Review 7.  A Synopsis of Clinical Pharmacokinetic Alterations in Advanced CKD.

Authors:  Thomas D Nolin
Journal:  Semin Dial       Date:  2015-04-08       Impact factor: 3.455

8.  The pharmacokinetics of nortriptyline in patients with chronic renal failure.

Authors:  S Dawlilng; K Lynn; R Rosser; R Braithwaite
Journal:  Br J Clin Pharmacol       Date:  1981-07       Impact factor: 4.335

Review 9.  Drug dosage in renal disease.

Authors:  L Dettli
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

10.  Drug dosage in end-stage renal disease (ESRD) patients undergoing haemodialysis. A predictive study based on a microcomputer program.

Authors:  M V Mac-Kay; J Sanchez Burson; J Martinez-Lanao; A Dominguez-Gil
Journal:  Clin Pharmacokinet       Date:  1993-09       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.